GLP-1-话题@MedSci

#GLP-1#

111篇内容 | 2152人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1422687, encodeId=14e1142268e5f, content=<a href='/topic/show?id=54fa80e701' target=_blank style='color:#2F92EE;'>#GLP-1#</a>, objectTitle=Diabetes Care：GLP-1受体激动剂可以作为青少年的成年发病型糖尿病(MODY)3型的替代治疗, objectType=article, longId=36769, objectId=f77936e69cd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f77936e69cd, replyNumber=0, likeNumber=33, createdTime=2014-06-21, rootId=0, userName=yibei, userId=f8f23732777, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f77936e69cd, moduleTitle=Diabetes Care：GLP-1受体激动剂可以作为青少年的成年发病型糖尿病(MODY)3型的替代治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f77936e69cd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1422686, encodeId=07311422686fb, content=<a href='/topic/show?id=54fa80e701' target=_blank style='color:#2F92EE;'>#GLP-1#</a>, objectTitle=ADA 2014：**奖授予GLP-1研究领域奠基人, objectType=article, longId=36596, objectId=508c365968e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=508c365968e, replyNumber=0, likeNumber=23, createdTime=2014-06-20, rootId=0, userName=yibei, userId=f8f23732777, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=508c365968e, moduleTitle=ADA 2014：**奖授予GLP-1研究领域奠基人, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=508c365968e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1422685, encodeId=c540142268518, content=<a href='/topic/show?id=54fa80e701' target=_blank style='color:#2F92EE;'>#GLP-1#</a>, objectTitle=Neuropharmacology：GLP-1受体可能是慢性疼痛的关键靶点, objectType=article, longId=34479, objectId=7bd1344e902, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7bd1344e902, replyNumber=0, likeNumber=49, createdTime=2014-05-10, rootId=0, userName=yibei, userId=f8f23732777, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7bd1344e902, moduleTitle=Neuropharmacology：GLP-1受体可能是慢性疼痛的关键靶点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7bd1344e902)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1422684, encodeId=ce011422684be, content=<a href='/topic/show?id=54fa80e701' target=_blank style='color:#2F92EE;'>#GLP-1#</a>, objectTitle=Gastroenterology：阻断GLP-1受体或可治疗胃旁路术后低血糖, objectType=article, longId=31158, objectId=bbb53115823, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bbb53115823, replyNumber=0, likeNumber=40, createdTime=2014-02-27, rootId=0, userName=yibei, userId=f8f23732777, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bbb53115823, moduleTitle=Gastroenterology：阻断GLP-1受体或可治疗胃旁路术后低血糖, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bbb53115823)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1422683, encodeId=a4671422683f7, content=<a href='/topic/show?id=54fa80e701' target=_blank style='color:#2F92EE;'>#GLP-1#</a>, objectTitle=胰高血糖素样肽-1（GLP-1）保护胰岛β细胞相关分子机制的研究进展, objectType=article, longId=28933, objectId=497a2893332, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=497a2893332, replyNumber=0, likeNumber=38, createdTime=2014-01-05, rootId=0, userName=yibei, userId=f8f23732777, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=497a2893332, moduleTitle=胰高血糖素样肽-1（GLP-1）保护胰岛β细胞相关分子机制的研究进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=497a2893332)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1422682, encodeId=24d31422682de, content=<a href='/topic/show?id=54fa80e701' target=_blank style='color:#2F92EE;'>#GLP-1#</a>, objectTitle=朱大龙：GLP-1降糖药物的临床应用共识, objectType=article, longId=27158, objectId=0d702e158ff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0d702e158ff, replyNumber=0, likeNumber=46, createdTime=2013-11-28, rootId=0, userName=yibei, userId=f8f23732777, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0d702e158ff, moduleTitle=朱大龙：GLP-1降糖药物的临床应用共识, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0d702e158ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1422681, encodeId=35181422681f2, content=<a href='/topic/show?id=54fa80e701' target=_blank style='color:#2F92EE;'>#GLP-1#</a>, objectTitle=CDS 2013：郭立新教授谈新型糖尿病药物GLP-1新近进展, objectType=article, longId=27009, objectId=79852e00964, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=79852e00964, replyNumber=0, likeNumber=45, createdTime=2013-11-25, rootId=0, userName=yibei, userId=f8f23732777, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=79852e00964, moduleTitle=CDS 2013：郭立新教授谈新型糖尿病药物GLP-1新近进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=79852e00964)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1422680, encodeId=0414142268084, content=<a href='/topic/show?id=54fa80e701' target=_blank style='color:#2F92EE;'>#GLP-1#</a>, objectTitle=Sanofi推迟GLP-1受体激动剂lixisenatide在FDA的申请, objectType=article, longId=24431, objectId=a5022443132, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a5022443132, replyNumber=0, likeNumber=0, createdTime=2013-09-15, rootId=0, userName=yibei, userId=f8f23732777, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a5022443132, moduleTitle=Sanofi推迟GLP-1受体激动剂lixisenatide在FDA的申请, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a5022443132)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1422679, encodeId=c17614226e995, content=<a href='/topic/show?id=54fa80e701' target=_blank style='color:#2F92EE;'>#GLP-1#</a>, objectTitle=FDA推迟审查葛兰素史克GLP-1类降糖药albiglutide, objectType=article, longId=22663, objectId=12a522663c9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=12a522663c9, replyNumber=0, likeNumber=46, createdTime=2013-08-07, rootId=0, userName=yibei, userId=f8f23732777, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=12a522663c9, moduleTitle=FDA推迟审查葛兰素史克GLP-1类降糖药albiglutide, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=12a522663c9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1422678, encodeId=8e4314226e8c0, content=<a href='/topic/show?id=54fa80e701' target=_blank style='color:#2F92EE;'>#GLP-1#</a>, objectTitle=BMJ：GLP-1类药物的安全性受到质疑, objectType=article, longId=20102, objectId=81602010295, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=81602010295, replyNumber=0, likeNumber=38, createdTime=2013-06-15, rootId=0, userName=yibei, userId=f8f23732777, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=81602010295, moduleTitle=BMJ：GLP-1类药物的安全性受到质疑, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=81602010295)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1422677, encodeId=4c5414226e7c3, content=<a href='/topic/show?id=54fa80e701' target=_blank style='color:#2F92EE;'>#GLP-1#</a>, objectTitle=PUDF 2013：母义明-GLP-1受体激动剂，它们都一样吗？, objectType=article, longId=19468, objectId=1004194680a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1004194680a, replyNumber=0, likeNumber=42, createdTime=2013-06-01, rootId=0, userName=yibei, userId=f8f23732777, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1004194680a, moduleTitle=PUDF 2013：母义明-GLP-1受体激动剂，它们都一样吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1004194680a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1422676, encodeId=fc6614226e6b5, content=<a href='/topic/show?id=54fa80e701' target=_blank style='color:#2F92EE;'>#GLP-1#</a>, objectTitle=AACE和ADA关于GLP-1类似物与胰腺炎风险性有关的联合声明, objectType=article, longId=19112, objectId=ef9a191128c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ef9a191128c, replyNumber=0, likeNumber=28, createdTime=2013-05-24, rootId=0, userName=yibei, userId=f8f23732777, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ef9a191128c, moduleTitle=AACE和ADA关于GLP-1类似物与胰腺炎风险性有关的联合声明, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ef9a191128c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1422675, encodeId=2c4014226e5a1, content=<a href='/topic/show?id=54fa80e701' target=_blank style='color:#2F92EE;'>#GLP-1#</a>, objectTitle=GLP-1类糖尿病药物的胰腺炎风险引起监管机构重视, objectType=article, longId=18500, objectId=f2cf185009a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f2cf185009a, replyNumber=0, likeNumber=44, createdTime=2013-05-11, rootId=0, userName=yibei, userId=f8f23732777, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f2cf185009a, moduleTitle=GLP-1类糖尿病药物的胰腺炎风险引起监管机构重视, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f2cf185009a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1422674, encodeId=c01d14226e443, content=<a href='/topic/show?id=54fa80e701' target=_blank style='color:#2F92EE;'>#GLP-1#</a>, objectTitle=AACE和ADA关于GLP-1类似物与胰腺炎风险性有关的联合声明, objectType=article, longId=15949, objectId=00aa1594925, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=00aa1594925, replyNumber=0, likeNumber=46, createdTime=2013-03-11, rootId=0, userName=yibei, userId=f8f23732777, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=00aa1594925, moduleTitle=AACE和ADA关于GLP-1类似物与胰腺炎风险性有关的联合声明, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=00aa1594925)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1422673, encodeId=212d14226e3d5, content=<a href='/topic/show?id=54fa80e701' target=_blank style='color:#2F92EE;'>#GLP-1#</a>, objectTitle=JAMA Pediatr:GLP-1受体激动剂抗青少年重度肥胖, objectType=article, longId=15216, objectId=a583152166d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a583152166d, replyNumber=0, likeNumber=38, createdTime=2013-02-19, rootId=0, userName=yibei, userId=f8f23732777, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a583152166d, moduleTitle=JAMA Pediatr:GLP-1受体激动剂抗青少年重度肥胖, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a583152166d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1422672, encodeId=264f14226e272, content=<a href='/topic/show?id=54fa80e701' target=_blank style='color:#2F92EE;'>#GLP-1#</a>, objectTitle=Brian Research：GLP-1对老年痴呆症治疗有效, objectType=article, longId=12734, objectId=784812e349b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=784812e349b, replyNumber=0, likeNumber=51, createdTime=2012-12-12, rootId=0, userName=yibei, userId=f8f23732777, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=784812e349b, moduleTitle=Brian Research：GLP-1对老年痴呆症治疗有效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=784812e349b)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

GLP-1

2020-05-29

yibei (审核中...)

前往app查看评论内容

#GLP-1#

Diabetes Care：GLP-1受体激动剂可以作为青少年的成年发病型糖尿病(MODY)3型的替代治疗

2014-06-21

yibei (审核中...)

前往app查看评论内容

#GLP-1#

ADA 2014：**奖授予GLP-1研究领域奠基人

2014-06-20

yibei (审核中...)

前往app查看评论内容

#GLP-1#

Neuropharmacology：GLP-1受体可能是慢性疼痛的关键靶点

2014-05-10

yibei (审核中...)

前往app查看评论内容

#GLP-1#

Gastroenterology：阻断GLP-1受体或可治疗胃旁路术后低血糖

2014-02-27

yibei (审核中...)

前往app查看评论内容

#GLP-1#

胰高血糖素样肽-1（GLP-1）保护胰岛β细胞相关分子机制的研究进展

2014-01-05

yibei (审核中...)

前往app查看评论内容

#GLP-1#

朱大龙：GLP-1降糖药物的临床应用共识

2013-11-28

yibei (审核中...)

前往app查看评论内容

#GLP-1#

CDS 2013：郭立新教授谈新型糖尿病药物GLP-1新近进展

2013-11-25

yibei (审核中...)

前往app查看评论内容

#GLP-1#

Sanofi推迟GLP-1受体激动剂lixisenatide在FDA的申请

2013-09-15

yibei (审核中...)

前往app查看评论内容

#GLP-1#

FDA推迟审查葛兰素史克GLP-1类降糖药albiglutide

2013-08-07

yibei (审核中...)

前往app查看评论内容

#GLP-1#

BMJ：GLP-1类药物的安全性受到质疑

2013-06-15

yibei (审核中...)

前往app查看评论内容

#GLP-1#

PUDF 2013：母义明-GLP-1受体激动剂，它们都一样吗？

2013-06-01

yibei (审核中...)

前往app查看评论内容

#GLP-1#

AACE和ADA关于GLP-1类似物与胰腺炎风险性有关的联合声明

2013-05-24

yibei (审核中...)

前往app查看评论内容

#GLP-1#

GLP-1类糖尿病药物的胰腺炎风险引起监管机构重视

2013-05-11

yibei (审核中...)

前往app查看评论内容

#GLP-1#

AACE和ADA关于GLP-1类似物与胰腺炎风险性有关的联合声明

2013-03-11

yibei (审核中...)

前往app查看评论内容

#GLP-1#

JAMA Pediatr:GLP-1受体激动剂抗青少年重度肥胖

2013-02-19

yibei (审核中...)

前往app查看评论内容

#GLP-1#

Brian Research：GLP-1对老年痴呆症治疗有效

2012-12-12

科室
- - 订阅+
  - 更多科室
工具
服务